Internal Medicine · Greeley, CO
NPI
1225011554
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2010 16th St Ste C
Greeley, CO, 80631
Phone (970) 392-2026
Groups this clinician bills Medicare through
Medicare paid, 2024
$170K
5,147 services
Medicare patients, 2024
440
Average age 76
Drug cost, 2024
$652K
7,244 prescriptions
Company payments, 2025
$939
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven M Kalt was code 36415 (venipuncture blood collection), 428 times for 262 patients. In total Steven M Kalt billed 5,147 services in 87 codes, and Medicare paid $170K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 428 | 262 | $8.63 | $3,694 |
| 85025 Blood Count | Office | 328 | 267 | $7.59 | $2,488 |
| 80053 Clinical Chemistry | Office | 325 | 258 | $10.32 | $3,353 |
| 80061 Clinical Chemistry | Office | 279 | 244 | $13.12 | $3,660 |
| 99214 Office E&M - Established | Office | 273 | 187 | $94.84 | $26K |
| 81001 Clinical Chemistry | Office | 271 | 242 | $3.09 | $837 |
| 99215 Office E&M - Established | Office | 246 | 246 | $120.83 | $30K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 229 | 229 | $129.69 | $30K |
| 83036 Blood Count | Office | 210 | 161 | $9.52 | $1,999 |
| 99213 Office E&M - Established | Office | 206 | 171 | $66.35 | $14K |
| 84443 Clinical Chemistry | Office | 176 | 167 | $16.46 | $2,897 |
| 82550 Clinical Chemistry | Office | 168 | 162 | $6.38 | $1,072 |
| 82306 Clinical Chemistry | Office | 152 | 142 | $29.01 | $4,410 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 82 | 82 | $18.92 | $1,551 |
| 80048 Clinical Chemistry | Office | 69 | 45 | $8.29 | $572 |
By year: 2022 $181K for 5,387 services; 2023 $164K for 4,956 services; 2024 $170K for 5,147 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 428 | 262 | $8.63 | $3,694 |
| 85025 Blood Count | 328 | 267 | $7.59 | $2,488 |
| 80053 Clinical Chemistry | 325 | 258 | $10.32 | $3,353 |
| 80061 Clinical Chemistry | 279 | 244 | $13.12 | $3,660 |
| 81001 Clinical Chemistry | 271 | 242 | $3.09 | $837 |
| 83036 Blood Count | 210 | 161 | $9.52 | $1,999 |
| 84443 Clinical Chemistry | 176 | 167 | $16.46 | $2,897 |
| 82550 Clinical Chemistry | 168 | 162 | $6.38 | $1,072 |
| 82306 Clinical Chemistry | 152 | 142 | $29.01 | $4,410 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 82 | 82 | $18.92 | $1,551 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven M Kalt prescribed most often to Medicare patients was Atorvastatin Calcium, with 516 prescriptions and refills. In total Steven M Kalt wrote 7,244 Medicare prescriptions that cost $652K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 516 | 1,460 | 148 | $6,950 |
| Levothyroxine Sodium Generic | 381 | 938 | 88 | $4,042 |
| Rosuvastatin Calcium Generic | 370 | 983 | 120 | $6,145 |
| Amlodipine Besylate Generic | 348 | 894 | 87 | $2,278 |
| Losartan Potassium Generic | 279 | 710 | 68 | $3,099 |
| Metoprolol Succinate Generic | 254 | 689 | 66 | $5,000 |
| Lisinopril Generic | 231 | 610 | 59 | $2,038 |
| Omeprazole Generic | 227 | 599 | 65 | $3,197 |
| Simvastatin Generic | 195 | 519 | 46 | $1,944 |
| Metformin Hcl Generic | 187 | 526 | 53 | $1,771 |
| Tamsulosin Hcl Generic | 144 | 384 | 36 | $2,826 |
| Alprazolam Generic | 111 | 119 | 29 | $600 |
| Hydrochlorothiazide Generic | 103 | 267 | 29 | $482 |
| Ezetimibe Generic | 102 | 247 | 31 | $2,085 |
| Eliquis Apixaban | 97 | 189 | 20 | $102K |
Brand drugs: 751 claims; generic drugs: 6,480 claims; opioid claims: 120.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven M Kalt $939 ($939 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novo Nordisk Inc with $176.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 4 | $176 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $155 |
| Abbvie Inc. ABBV | 2 | $149 |
| Amgen Inc. AMGN | 2 | $132 |
| Abbott Laboratories ABT | 2 | $124 |
| Evoke Pharma, Inc. EVOK | 1 | $100 |
| Pfizer Inc. PFE | 3 | $54.28 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $18.75 |
| Exact Sciences Corporation EXAS | 1 | $15.02 |
| Surgenex LLC | 1 | $14.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.